Cellectis (CLLS) EBT Margin (QoQ) (2015 - 2026)
Cellectis (CLLS) EBT Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
69,706.00 |
| Dec 31, 2025 |
-94,390.00 |
| Sep 30, 2025 |
-3,567.00 |
| Jun 30, 2025 |
10,747.00 |
| Mar 31, 2025 |
29,801.00 |
| Dec 31, 2024 |
-48,795.00 |
| Sep 30, 2024 |
-14,566.00 |
| Jun 30, 2024 |
10,046.00 |
| Mar 31, 2024 |
3.13 Mn |
| Dec 31, 2023 |
-2.20 Mn |
| Sep 30, 2023 |
-499,293.00 |
| Jun 30, 2023 |
845,291.00 |
| Mar 31, 2023 |
-1.26 Mn |
| Dec 31, 2022 |
632,915.00 |
| Sep 30, 2022 |
-532,475.00 |
| Jun 30, 2022 |
-68,463.00 |
| Mar 31, 2022 |
-26,871.00 |
| Dec 31, 2021 |
44,095.00 |
| Sep 30, 2021 |
-17,435.00 |
| Jun 30, 2021 |
-29,620.00 |
